American Oncology Network Past Earnings Performance
Past criteria checks 0/6
American Oncology Network's earnings have been declining at an average annual rate of -56.5%, while the Healthcare industry saw earnings growing at 4.6% annually. Revenues have been growing at an average rate of 17% per year.
Key information
-56.5%
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 17.0% |
| Return on equity | -51.0% |
| Net Margin | -0.7% |
| Next Earnings Update | 15 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How American Oncology Network makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,279 | -9 | 103 | 0 |
| 30 Sep 23 | 1,255 | -2 | 99 | 0 |
| 30 Jun 23 | 1,216 | 3 | 97 | 0 |
| 31 Mar 23 | 1,191 | 8 | 97 | 0 |
| 31 Dec 22 | 1,150 | 0 | 89 | 0 |
| 30 Sep 22 | 1,098 | -8 | 91 | 0 |
| 31 Dec 21 | 944 | 0 | 79 | 0 |
| 31 Dec 20 | 725 | 19 | 51 | 0 |
| 31 Dec 19 | 320 | 3 | 22 | 0 |
Quality Earnings: AONC is currently unprofitable.
Growing Profit Margin: AONC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AONC is unprofitable, and losses have increased over the past 5 years at a rate of 56.5% per year.
Accelerating Growth: Unable to compare AONC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AONC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.5%).
Return on Equity
High ROE: AONC has a negative Return on Equity (-51.01%), as it is currently unprofitable.